- Home
- PTCT vs KRC Comparison
PTCT vs KRC Comparison
Compare PTCT & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- KRC
- Stock Information
- Founded
- PTCT 1998
- KRC 1947
- Country
- PTCT United States
- KRC United States
- Employees
- PTCT N/A
- KRC N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- KRC Real Estate Investment Trusts
- Sector
- PTCT Health Care
- KRC Real Estate
- Exchange
- PTCT Nasdaq
- KRC Nasdaq
- Market Cap
- PTCT 5.3B
- KRC 4.8B
- IPO Year
- PTCT 2013
- KRC 1997
- Fundamental
- Price
- PTCT $68.31
- KRC $42.25
- Analyst Decision
- PTCT Buy
- KRC Hold
- Analyst Count
- PTCT 15
- KRC 12
- Target Price
- PTCT $67.67
- KRC $40.25
- AVG Volume (30 Days)
- PTCT 949.1K
- KRC 1.3M
- Earning Date
- PTCT 11-04-2025
- KRC 10-27-2025
- Dividend Yield
- PTCT N/A
- KRC 5.11%
- EPS Growth
- PTCT N/A
- KRC 62.23
- EPS
- PTCT 7.72
- KRC 2.71
- Revenue
- PTCT $1,764,929,000.00
- KRC $1,126,859,000.00
- Revenue This Year
- PTCT $119.02
- KRC N/A
- Revenue Next Year
- PTCT N/A
- KRC $5.82
- P/E Ratio
- PTCT $8.85
- KRC $15.59
- Revenue Growth
- PTCT 96.00
- KRC 0.77
- 52 Week Low
- PTCT $35.95
- KRC $27.07
- 52 Week High
- PTCT $69.88
- KRC $45.03
- Technical
- Relative Strength Index (RSI)
- PTCT 64.81
- KRC 58.16
- Support Level
- PTCT $66.00
- KRC $40.60
- Resistance Level
- PTCT $69.88
- KRC $43.23
- Average True Range (ATR)
- PTCT 2.24
- KRC 1.02
- MACD
- PTCT -0.30
- KRC 0.16
- Stochastic Oscillator
- PTCT 71.61
- KRC 71.92
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 17 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.